Life Sciences R&D & Medical

Canada pharma looks to data to improve patient support program impact

By Rob Chalmers, Max Bradshaw, Michelle Gao, and Dan Zimskind

Oct. 26, 2021 | Infographic | 3 minutes read

Canada pharma looks to data to improve patient support program impact


In ZS’s survey of Canadian pharmaceutical companies, we uncovered their plans to more fully use patient support program data, real-world evidence and artificial intelligence/advanced analytics to help improve health outcomes. Here’s a look at the initiatives they plan to implement in the next 24 months.

Add insights to your inbox

We’ll send you content you’ll want to read – and put to use.



About the author(s)